Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 657, pseudogene (RN7SL657P)
- Target
- RN7SL657P
- Molecular classification
- Pseudogene, Noncoding RNA (processed pseudogene)
01
Overview
RN7SL657P is classified as a processed pseudogene derived from RNA, 7SL, cytoplasmic 657, which itself is the RNA component of the signal recognition particle (SRP)[1][5]. In humans, the functional 7SL RNA is essential for targeting newly synthesized proteins to membranes[3][4]. However, RN7SL657P does not produce a functional RNA and has no documented physiological or therapeutic role[1][5][6]. The majority of 7SL RNA-like sequences in the human genome are pseudogenes, remnants from the reverse flow of genetic material from RNA back into DNA; they show truncated and diverse structures but are not expressed[5][6].
- Other names
- RN7SL657PRNA, 7SL, cytoplasmic 657, pseudogene
02
Mechanism of action
None (No mechanisms of action described for drugs targeting this pseudogene)
03
Biological functions
None (No known biological function for RN7SL657P itself; pseudogenes generally do not encode proteins or RNAs with canonical biological function)
04
Disease associations
None (No evidence linking RN7SL657P to disease roles; while some pseudogenes can regulate gene expression and have been implicated in disease, there is no information supporting a role for RN7SL657P)
05
Safety considerations
None (It is not a therapeutic target so no safety concerns are noted)
06
Interacting drugs
None (No drugs interact with RN7SL657P)
07
Biomarkers
None (This pseudogene is not described as a biomarker)
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 657, pseudogene (RN7SL657P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 657, pseudogene (RN7SL657P).